Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Acute Stent Thrombosis Associated with Lipid Core Plaque as Detected by LipiScan Near-Infrared Spectroscopy Imaging System

InfraReDx announced that James E. Muller, M.D., founder and chief executive officer, will be presenting at the 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference

InfraReDx announced the upcoming presentation of three LipiScan™-related scientific abstracts at the American Heart Association Scientific Sessions 2010 (AHA 2010)

InfraReDx announced its new LipiScan IVUS Coronary Imaging System will be highlighted during the annual Transcatheter Cardiovascular Therapeutics meeting ( TCT 2010 ).

InfraReDx , Inc. received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the LipiScan IVUS Coronary Imaging System.

Read more...